Brind.

Merck KGaA and Promega are key players in the GPCR targeting market.

1 report, 1 independent Updated Jul 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Merck KGaA and Promega are key players in the GPCR targeting market.

Who's involved

What this event is mainly about
Merck KGaAPromega

Keep exploring

The entities involved

  • Merck KGaA

    German multinational science and technology company

    Nothing else this week.

  • Promega

    biotechnology company

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • PR NewswireG-Protein Coupled Receptor (GPCR) Targeting Technologies Market on the Rise "Highlighting Strategic Alliances and Innovation, the Global GPCR Targeting Market Report Explores the Role of GPCRs in Dru